DocGo (DCGO) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is DocGo Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of DocGo is: No Data: Cannot be evaluated.

Competitive Comparison of DocGo's Risk Assessment

For the Medical Care Facilities subindustry, DocGo's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DocGo's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's Risk Assessment distribution charts can be found below:

* The bar in red indicates where DocGo's Risk Assessment falls into.

DocGo (NAS:DCGO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

DocGo Risk Assessment Related Terms

Thank you for viewing the detailed overview of DocGo's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

DocGo (DCGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 West 35th Street, Floor 6, New York, NY, USA, 10001

Website

https://www.docgo.com

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.

Executives

Stephen Sugrue	officer: Chief Compliance Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Lee Bienstock	officer: Chief Operating Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Ely D Tendler	director, officer: General Counsel, Secretary	STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Anthony Capone	officer: President	106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer	officer: Chief Financial Officer	35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite	director	5477 VIA NICOLA, NEWBURY PARK CA 91320
Michael J Burdiek	director	39 PARKER, IRVINE CA 92618
Ira Smedra	director	401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin	officer: CMO, Ambulnz Holdings, LLC	35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski	officer: Chief Compliance Officer	PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo	director	3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405
Norman Rosenberg	officer: CFO, Ambulnz Holdings, LLC	51 MOUNTAIN AVENUE, MONSEY NY 10952
Stanley Vashovsky	director, 10 percent owner, officer: Chief Executive Officer	763 RALEIGH STREET, WOODMERE NY 11598
Steven Katz	director	20 REBEL RUN DR, EAST BRUNSWICK NJ 08816